Lipoxin A4-Induced Heme Oxygenase-1 Protects Cardiomyocytes against Hypoxia/Reoxygenation Injury via p38 MAPK Activation and Nrf2/ARE Complex

Effect of Lipoxin A4 on Myocardial Ischemia Reperfusion Injury Following Cardiac Arrest in a Rabbit Model

(2012) Zhiqiao Chen et al.   INFLAMMATION

2-Methoxycinnamaldehyde from Cinnamomum cassia reduces rat myocardial ischemia and reperfusion injury in vivo due to HO-1 induction

(2011) Jeong Seok Hwa et al.   JOURNAL OF ETHNOPHARMACOLOGY

Ischemia and reperfusion—from mechanism to translation

(2011) Holger K Eltzschig et al.   NATURE MEDICINE

Effect of Lipoxin A4on Lipopolysaccharide-Induced Endothelial Hyperpermeability

(2011) Huayan Pang et al.   TheScientificWorldJOURNAL

Lipoxin A4 Inhibits Transition of Epithelial to Mesenchymal Cells in Proximal Tubules

(2010) Sheng-Hua Wu et al.   AMERICAN JOURNAL OF NEPHROLOGY

Palmatine from Coptidis rhizoma reduces ischemia–reperfusion-mediated acute myocardial injury in the rat

(2009) Young Min Kim et al.   FOOD AND CHEMICAL TOXICOLOGY

Targeting p38-MAPK in the ischaemic heart: kill or cure?

(2008) R BASSI et al.   CURRENT OPINION IN PHARMACOLOGY

Signal pathway involved in inhibition by lipoxin A4 of production of interleukins induced in endothelial cells by lipopolysaccharide

(2008) Sheng-Hua Wu et al.   INFLAMMATION RESEARCH

BML-111, a lipoxin receptor agonist, modulates the immune response and reduces the severity of collagen-induced arthritis

(2008) L. Zhang et al.   INFLAMMATION RESEARCH

A Novel Peptide Agonist of Formyl-Peptide Receptor-Like 1 (ALX) Displays Anti-Inflammatory and Cardioprotective Effects

(2008) I. Hecht et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus

(2007) C N Serhan et al.   BRITISH JOURNAL OF PHARMACOLOGY